Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study. - Ersoy M; Kefeli U; Cabuk D; Bayram E; Bayir D; Bozkurt O; Ürün M; Coşar R; Sakalar T; Mutlu E; Cengiz M; Sahin E; et al. (Frontiers in immunology, 2026)